![Clinical trials / Epidemiology / Medical research / Medical terms / Prodrugs / Biomarker / Irinotecan / Surrogate endpoint / CYP3A4 / Medicine / Chemistry / Health Clinical trials / Epidemiology / Medical research / Medical terms / Prodrugs / Biomarker / Irinotecan / Surrogate endpoint / CYP3A4 / Medicine / Chemistry / Health](/pdf-icon.png) Date: 2004-10-14 14:44:52Clinical trials Epidemiology Medical research Medical terms Prodrugs Biomarker Irinotecan Surrogate endpoint CYP3A4 Medicine Chemistry Health | | Topic 1 Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism 1. Is the pharmacokinetic and clinical evidence presented sufficient to demonstrate that homozygous UGT1A1*28 genotypes (7/7 geAdd to Reading ListSource URL: www.fda.govDownload Document from Source Website File Size: 33,00 KBShare Document on Facebook
|